Outpatient Macrolide Antibiotic Prescribing in the United States, 2008-2011.
Guillermo V Sanchez, Daniel J Shapiro, Adam L Hersh, Lauri A Hicks, Katherine E Fleming-Dutra
Author Information
Guillermo V Sanchez: Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Daniel J Shapiro: Boston Children's Hospital, Boston, Massachusetts.
Adam L Hersh: Pediatric Infectious Diseases, University of Utah School of Medicine, Salt Lake City, Utah.
Lauri A Hicks: Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Katherine E Fleming-Dutra: Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
National Ambulatory Medical Care Survey data were used to assess outpatient macrolide prescribing and selection. Conditions for which macrolides are firstline therapy represented 5% of macrolide prescribing. Family practitioners selected macrolides for children more frequently than pediatricians. Macrolides are an important antibiotic stewardship target.
